Belgium - Lipid Modifying Medicine Use
Since 2014, Belgium Lipid Modifying Medicine Use increased 2.1% year on year. In 2019, the country was ranked number 4 among other countries in Lipid Modifying Medicine Use at 145.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Belgium is overtaken by Norway, which was ranked number 3 at 147.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Slovenia at 142 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% compared to 2018. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia recorded the worst performance at -8.7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 145.50 |
| 2018 | 141.80 |
| 2017 | 137.50 |
| 2016 | 136.30 |
| 2015 | 133.30 |
How does Belgium rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data |
| 3 |
#3
Norway
|
148 | 2019 | +3.8 % | +3.6 % | View data |
| 4 |
#4
Belgium
|
146 | 2019 | +2.6 % | +2.1 % | View data |
| 5 |
#5
Slovenia
|
142 | 2019 | +3.0 % | +4.8 % | View data |